Publication - Abstract
Mar 13, 2021
Molecular Therapy Nucleic Acids
N. Davies, D. Hovdal, N. Edmunds, P. Nordberg, S. Andersson, et. al.
Lipid nanoparticles (LNPs) are the most clinically advanced delivery system for RNA-based drugs but have predominantly been investigated for intravenous and intramuscular administration. Subcutaneous administration opens the possibility of patient self-administration and hence lo...
Read More
Publication - Abstract
May 07, 2018
Bioconjugate Chemistry
J. Bteich, M.J. Ernsting, M.Z. Mohammed, T. Kiyota, T. D. McKee, M. Trikha, H.B. Lowman and K.K. Sokoll
Nanoparticles provide a unique opportunity to explore the benefits of selective distribution and release of cancer therapeutics at sites of disease through varying particle sizes and compositions that exploit the enhanced permeability of tumor-associated blood vessels.
Read More